Tagged with R

Rx&D You have been President of Rx&D since 2004, and have witnessed the market’s development over the years. What have been the most important issues since you started and what are you most proud of? Our industry is developing partnerships with governments, universities, patient groups, biotechs to bring about the best…

Nordics Mary Di Marzio has been General Manager of Nordics for Shire Inc for nearly 2 years now. Today she shares with Pharmaboardroom the progress of Shire’s relatively new branch in Scandinavia. She continues to give insights into the balancing act between pricing versus reimbursement and how they are raising awareness…

Le Meridien Jakarta As the general manager of Le Meridien Jakarta, what is your point of view on the evolution of Jakarta’s infrastructure? Do you believe that hosting the APEC 2013 will put Indonesia more in the spotlight? Definitely. I believe that Jakarta and Indonesia– not only just because of the APEC –…

Austria   Historically, Austria was the dominant political power in Central Europe under the Habsburg dynasty which ruled until World War I. Although the 20th century has been marked by significant shake ups and power shifts between countries in Europe, Austria remains today a key strategic market thanks to its steady economic…

Novartis In our last meeting, you said that you were looking forward to a decade of continuous growth and to be the number one partner of choice for patients, physicians, governments and institutions. In what way have you been able to do that? Novartis Colombia has a broader portfolio compared to…

Espíndola International Consultants An expert in trade and regulatory issues relating to the pharmaceutical industry in Colombia, the senior partner of Espíndola International Consultants offers his opinions on the steps taken by the Colombian authorities to improve quality and reduce corruption in the sector, as well as discussing the steps to maintain cost containment…

IMS Health Ireland Mr. Egan, what path led you to IMS Health? My original background is in science—I received a PhD in medical microbiology, and worked for some time as a post-doctoral researcher for a Swedish biotech company that was contracting research services here in Ireland. I have since hung up my lab…

Mexico Beyond the bright lights of Mexico City’s Santa Fe and Polanco districts, roughly half of Mexicans lack access to quality healthcare or medicines. This presents a challenge for pharma companies in terms of corporate social responsibility (CSR). To Miguel Múnera, general manager for Roche Mexico, CSR isn’t just a way…

Growth Why did MSD decide to have Denmark as the headquarters for the Mid Europe 2 region? This Mid Europe 2 region consists of 10 countries, most of them clustered around the Nordics, which include the Nordics, the Baltics, Switzerland and Austria. The region is characterized by stable economies with positive GDP…

Ireland Can you please introduce yourself, and Ernst & Young’s life science practice in Ireland, to our readers? I am the managing partner of Ernst & Young (EY) in Ireland, responsible for both the Republic of Ireland and Northern Ireland.I have been with EY since the start of my professional career…

Primecore Mr. Callaghan, you have had quite a long and prestigious career in the pharmaceutical industry, with experience overseeing manufacturing programs for giants such as Amgen, BMS and Merck. Can you give us an overview of your career path? My background is in chemical engineering—I am a process engineer. When I…

maintenance Mr. O’Neill, you have been managing director of this company for 17 years. How have you evolved the business over that period? ESS was founded in 1991, and I joined the business in 1996. The company’s initial vision was to provide flexibility to the maintenance market in Ireland and its…